In Silico Clinical Trials Market - Global Industry Size, Share, Trends, and Forecast 2027

Shipra Joshi

In Silico Clinical Trials Market - Global Industry Size, Share, Trends, and Forecast 2027

Global In Silico Clinical Trials market stood at USD2743.64 million in 2021 and is expected to grow at a CAGR of 12.28% during the forecast period. The growing factors of the market are: growing prevalence of various communicable and non-communicable diseases such as cancer, diabetes, cardiovascular diseases, neurological disorders, SARS-CoV-2 among others requiring different drugs and medical devices for the treatment.

Rapidly Increasing Concerns Over Animal Welfare

In January 2020, the US Department of Agriculture had reported that approximately 300,000 animals were involved in pain causing experimental activities in just one year. In silico clinical trials offer an effective way of replacing animal anatomies for conducting various experiments and research & development activities.

Benefits Associated with In Silico Clinical Trials

Numerous benefits associated with In Silico Clinical Trials such as their cost effectiveness in terms of pharmaceutical and therapeutic research, their ability to assess without any significant delays and additional resources thereby increasing their scalability, ensuring animal safety, among others are expected to support the market growth through 2027.

Market Segmentation

The global In Silico Clinical Trials market segmentation is based on industry, therapeutic area, region and company. Regionally, North America dominated the market in 2021 among Europe, Asia Pacific, South America and Middle East & Africa.

In North America, the United States dominated the market with an overall share of 77.01% in 2021 on account of increasing use case scenario in the United States such as the testing of mini-invasive total hip replacement known as Proximal Epiphyseal Replacement device designed by Stryker Corporation.

Company Profile:

Market Size value in 2021 - USD2743.64 Million

Revenue Forecast in 2027 - USD5451.19 Million

United States Market Size Value in 2021 - USD853.60 Million

Growth Rate - 12.28%

Base Year - 2021

Historical Years - 2017 – 2020

Estimated Year - 2022

Forecast Period - 2023 – 2027

Quantitative Units - Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report Coverage - Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered - Industry and Therapeutic Area

Regional Scope - North America; Europe; Asia Pacific; South America; Middle East & Africa

Country Scope - United States; Canada; Mexico; Germany; Italy; United Kingdom; France; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE

Key Companies Profiled - Dassault Systèmes SE, Certara Inc., Insilico Medicine, GNS Healthcare Inc., The AnyLogic Company, Novadiscovery SAS, InSilicoTrials Technologies SpA, Immunetrics Inc, CATO SMS, Evotec SE

Customization Scope - 10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and Purchase Options - Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format - PDF and Excel through Email (We can also provide the editable version of the report in PPT/pdf format on special request)

Table of Content:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global In Silico Clinical Trials Market

4. Executive Summary

5. Voice of Customer

5.1. Brand Awareness

5.2. Factors Contributing to Switch to In Silico Clinical Trials

5.3. Demand for In Silico Clinical Trials, By Therapeutic Area

5.4. Preference for In Silico Clinical Trials, By Industry

6. Global In Silico Clinical Trials Market Outlook, 2017-2027F

6.1. Market Size & Forecast

6.2. Market Share & Forecast

6.3. Product Market Map

7. North America In Silico Clinical Trials Market Outlook, 2017-2027F

7.1. Market Size & Forecast

7.2. Market Share & Forecast

7.3. North America: Country Analysis

7.3.2. Canada In Silico Clinical Trials Market Outlook

7.3.3. Mexico In Silico Clinical Trials Market Outlook

8. Europe In Silico Clinical Trials Market Outlook, 2017-2027F

9. Asia-Pacific In Silico Clinical Trials Market Outlook, 2017-2027F

10. South America In Silico Clinical Trials Market Outlook, 2017-2027F

11. Middle East and Africa In Silico Clinical Trials Market Outlook, 2017-2027F

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends and Developments

14. Competitive Landscape

14.1. Competition Outlook

14.2. Company Profiles

15. Strategic Recommendations

16. About Us & Disclaimer

Shipra Joshi

In Silico Clinical Trials Market Share, Size, Trend, Forecast, Analysis and Growth from 2022 to 2028

Mohit Joshi 2023-05-10

The analysis has been segmented into Industry (Medical Devices and Pharmaceuticals); Therapeutic Area(Oncology, Infectious Disease, Hematology, Cardiology, Dermatology, Neurology, Diabetes, and Others); Phase (Phase I, Phase II, Phase III, and Phase IV); Region/Country. The in silico clinical trials market report offers a detailed analysis of the latest industry developments and trending factors in the market that are influencing the market growth. com/report/in-silico-clinical-trials-market/In Silico Clinical Trials Market Geographical Segmentation Includes:· North America (United States, Canada, and Rest of North America)· Europe (Germany, United Kingdom, Spain, Italy, France, and the Rest of Europe)· Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific) · Rest of the WorldAsia Pacific’s in silico clinical trials market is expected to witness the fastest growth during the forecast period. The major players targeting the market include· Certara, USA· Nova. About UnivDatos Market Insights (UMI)Browse Other Related Research Reports from UnivDatos Market Insights· Multi Cancer Early Detection Market· Clinical Trials Market· Lung Cancer Therapeutics Market· Preclinical Imaging Market· E-Clinical Solutions Market

Growth Accelerated By Emerging Parallelism Of Traditional And Digital Clinical Trials

samruddhicmi12 2023-12-27

In silico clinical trials is an emerging field that uses computational techniques to model medical experiments involving virtual patients. The global In Silico Clinical Trials Market is estimated to be valued at US$ 3410. In silico clinical trials allow testing thousands of in silico patients and clinical scenarios rapidly and at a lower cost compared to physical clinical trials. As digital technologies become more advanced, their complementary use with traditional clinical trials will continue to expand, driving increased adoption of in silico simulations. Segment AnalysisThe global in silico clinical trials market is segmented based on product, therapeutic area, end user, and region. The global In Silico Clinical Trials Market is estimated to be valued at US$ 3410.

Global In Silico Clinical Trials Market Is Estimated To Witness High Growth Owing To Growing Demand For Virtual Clinical Trials

Vaishnavi Kashid 2023-08-30

The global In Silico Clinical Trials Market is estimated to be valued at US$ 3,173. A) Market Overview: Silico Clinical Trials are virtual trials conducted using computer models and simulations to evaluate drug efficacy and safety. B) Market Key Trends: One key trend in the In Silico Clinical Trials Market is the growing demand for virtual clinical trials. Economic: Silico Clinical Trials offer cost-effective solutions compared to traditional clinical trials. In conclusion, the In Silico Clinical Trials Market is witnessing significant growth due to the increasing demand for virtual trials.

The Global In Silico Clinical Trials Market Growth Accelerated By Advancement In Technologies

ashwinicmi 2023-12-18

In silico clinical trials use computer simulation and models to predict drug efficacy and safety. The global In Silico Clinical Trials Market is estimated to be valued at US$ 3,410. By end use, pharmaceutical and biotechnology companies extensively utilize in silico clinical trials solutions for efficient drug R&D with lower investments compared to physical trials. Regional analysis: North America holds the highest share in the In Silico Clinical Trials market mainly due to increasing investments by pharmaceutical giants for advanced drug discovery techniques. Additionally, favorable government initiatives are boosting adoption of novel technologies including virtual clinical trials in the region.

The In Silico Clinical Trials Market is estimated to witness high growth owing to adoption of artificial intelligence and machine learning models

Poonam 2023-11-24

The In Silico Clinical Trials Market is estimated to be valued at US$ 3,410. However, virtual trials reduce the costs compared to physical clinical trials which lowers the entry barriers. Competitive rivalry: is high due to presence of numerous global and regional players offering differentiated in silico clinical trial solutions. Key Takeaways The global In Silico Clinical Trials Market Growth is expected to witness high growth, exhibiting CAGR of 7. Key players operating in the in silico clinical trials market are Abzena Ltd.

Transforming Clinical Research: Exploring the In Silico Trials Market

Larry Paige 2023-06-22

The emergence of in silico trials is transforming the landscape of clinical research by offering a new and innovative approach to drug development. In silico trials, which involve computer simulations and virtual models, have gained significant attention and are poised to revolutionize the field. One of the key advantages of in silico trials is their potential to reduce the time and costs associated with traditional clinical trials. Furthermore, In Silico Clinical Trials Market contributes to the reduction of animal testing and ethical concerns associated with traditional clinical trials. The in silico trials market is rapidly expanding, with a growing number of pharmaceutical companies, contract research organizations, and technology providers investing in this field.

WHO TO FOLLOW